Vanguard Group Inc. Decreases Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Vanguard Group Inc. trimmed its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 1.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,578,419 shares of the company’s stock after selling 85,952 shares during the quarter. Vanguard Group Inc. owned 0.12% of Molina Healthcare worth $1,914,649,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. True Wealth Design LLC lifted its holdings in shares of Molina Healthcare by 2,500.0% in the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Versant Capital Management Inc raised its position in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock worth $47,000 after purchasing an additional 74 shares during the period. Wingate Wealth Advisors Inc. bought a new stake in Molina Healthcare in the fourth quarter worth about $52,000. EverSource Wealth Advisors LLC boosted its position in shares of Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $57,000 after buying an additional 88 shares during the period. Finally, Harvest Fund Management Co. Ltd grew its stake in shares of Molina Healthcare by 895.0% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock valued at $58,000 after buying an additional 179 shares during the last quarter. Institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares in the company, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.10% of the stock is owned by insiders.

Molina Healthcare Price Performance

NYSE MOH opened at $323.98 on Thursday. The company has a market cap of $17.72 billion, a PE ratio of 15.86, a P/E/G ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $423.92. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The firm’s 50 day moving average price is $300.69 and its 200-day moving average price is $308.97.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. Sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of research analyst reports. Mizuho decreased their price target on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. UBS Group reduced their target price on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. StockNews.com upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Barclays decreased their price objective on shares of Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a report on Friday, February 7th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $355.69.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.